Literature DB >> 12185224

Elbow fistulas using autogeneous vein: patency rates and results of revision.

G J Murphy1, R Saunders, M Metcalfe, M L Nicholson.   

Abstract

BACKGROUND: The provision and maintenance of vascular access remains a major cost to end stage renal failure programmes. There are few reports regarding the surgical revision of the failing native elbow arteriovenous fistula (AVF). PATIENTS AND METHODS: A retrospective case note review was performed on all patients identified from the hospital vascular access database as having undergone construction of an autogeneous vein elbow AVF. Over a seven year period 282 autogeneous vein AVFs were fashioned in 232 patients using the brachial artery as the in-flow conduit. Of these 208 were brachiocephalic fistulas, or a variant thereof, and 74 were fashioned using the transposed autologous basilic vein (136 male: 96 female; median age 60 years, range 14-94 years).
RESULTS: Of 282 elbow fistulas 197 were successfully used for dialysis (70%). Cumulative primary patency of elbow fistulas using autogeneous vein in this series was 68%, 54%, and 44% at one, two, and three years respectively. A further 34 revision procedures were performed on 28 fistulas to maintain fistula function, and cumulative secondary patency after surgical revision was 75%, 60%, and 46% at one, two, and three years. Overall 21 out of 34 procedures (62%) successfully restored fistula function and cumulative primary patency of the revised fistulas was 56% at one year. Eighteen AVFs (brachiocephalic, n=12; autologous basilar vein, n=6) required revision for access dysfunction secondary to a short stenoses within 4 cm of the arteriovenous anastomoses. Of these 18 AVFs eight were revised by excision of the stenosed segment and either primary anastomoses of the two cut ends of arterialised vein or reanastomoses of the proximal venous limb proximally on the brachial artery. In another nine fistulas the excised segment was replaced with a short interposition graft (polytetrafluoroethylene, n=7; native basilic vein, n=1; bovine carotid artery, n=1). One fistula with postanastomotic stenoses and a more proximal needle site stenoses was revised using two vein patches. Overall 100% were patent at 24 hours, 13 provided successful dialysis (72%), and cumulative primary patency was 67% and 50% at six months and one year respectively.
CONCLUSIONS: Successful surgical revision of failing native elbow fistulas can restore patency and improve cumulative secondary patency with potential benefits in terms of patient morbidity and mortality. These results compare favourably to published patency rates after fistula salvage using interventional radiological techniques.

Entities:  

Mesh:

Year:  2002        PMID: 12185224      PMCID: PMC1742455          DOI: 10.1136/pmj.78.922.483

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  22 in total

1.  Vascular access for hemodialysis.

Authors:  S J Schwab; J T Harrington; A Singh; R Roher; S A Shohaib; R D Perrone; K Meyer; D Beasley
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

2.  Surgical salvage of failed radiocephalic arteriovenous fistulae: techniques and results in 29 patients.

Authors:  D D Oakes; J P Sherck; L F Cobb
Journal:  Kidney Int       Date:  1998-02       Impact factor: 10.612

3.  Prospective randomized comparison of surgical versus endovascular management of thrombosed dialysis access grafts.

Authors:  W A Marston; E Criado; P F Jaques; M A Mauro; S J Burnham; B A Keagy
Journal:  J Vasc Surg       Date:  1997-09       Impact factor: 4.268

4.  Distal revascularization-interval ligation for limb salvage and maintenance of dialysis access in ischemic steal syndrome.

Authors:  S S Berman; A T Gentile; M H Glickman; J L Mills; R L Hurwitz; A Westerband; J M Marek; G C Hunter; C S McEnroe; M A Fogle; G K Stokes
Journal:  J Vasc Surg       Date:  1997-09       Impact factor: 4.268

5.  Prophylactic balloon angioplasty fails to prolong the patency of expanded polytetrafluoroethylene arteriovenous grafts: results of a prospective randomized study.

Authors:  A B Lumsden; M J MacDonald; D Kikeri; G A Cotsonis; L A Harker; L G Martin
Journal:  J Vasc Surg       Date:  1997-09       Impact factor: 4.268

6.  Long-term function of vascular access for hemodialysis.

Authors:  M A Enzler; T Rajmon; M Lachat; F Largiadèr
Journal:  Clin Transplant       Date:  1996-12       Impact factor: 2.863

7.  Elbow arteriovenous fistulas for chronic haemodialysis.

Authors:  J Elcheroth; L de Pauw; P Kinnaert
Journal:  Br J Surg       Date:  1994-07       Impact factor: 6.939

8.  Arteriovenous fistula using transposed basilic vein.

Authors:  P C Butterworth; T M Doughman; T J Wheatley; M L Nicholson
Journal:  Br J Surg       Date:  1998-05       Impact factor: 6.939

9.  Detection and treatment of dysfunctional hemodialysis access grafts: effect of a surveillance program on graft patency and the incidence of thrombosis.

Authors:  A A Safa; K Valji; A C Roberts; T W Ziegler; R J Hye; S B Oglevie
Journal:  Radiology       Date:  1996-06       Impact factor: 11.105

10.  Hemodialysis vascular access morbidity in the United States.

Authors:  H I Feldman; P J Held; J T Hutchinson; E Stoiber; M F Hartigan; J A Berlin
Journal:  Kidney Int       Date:  1993-05       Impact factor: 10.612

View more
  3 in total

1.  High rate of fistula placement in a cohort of dialysis patients in a single payer system.

Authors:  Christopher D Blosser; Gashu Ayehu; Sam Wu; Ruth M Lomagro; Ellen Malone; Steven M Brunelli; Max Itkin; Michael Golden; Peter McCombs; Joshua H Lipschutz
Journal:  Hemodial Int       Date:  2010-08-31       Impact factor: 1.812

2.  The primary arteriovenous fistula failure-a comparison between diabetic and non-diabetic patients: glycemic control matters.

Authors:  Baris Afsar; Rengin Elsurer
Journal:  Int Urol Nephrol       Date:  2011-05-07       Impact factor: 2.370

3.  Upper Arm Basilic Vein Transposition for Hemodialysis: A Single Center Study for 300 Cases.

Authors:  Yunhee Lee; Dan Song; Myung Jin Kim; Sang Chul Yun
Journal:  Vasc Specialist Int       Date:  2016-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.